Antibody data
- Antibody Data
- Antigen structure
- References [74]
- Comments [0]
- Validations
- Western blot [1]
- Immunocytochemistry [2]
- Chromatin Immunoprecipitation [1]
- Other assay [2]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MA1-12626 - Provider product page
- Provider
- Invitrogen Antibodies
- Product name
- Progesterone Receptor Antibody Cocktail
- Antibody type
- Monoclonal
- Antigen
- Other
- Description
- MA1-12626 detects Progesterone Receptor in human, equine and porcine samples.
- Antibody clone number
- hPRa2, hPRa3
- Concentration
- 1 mg/mL
Submitted references Equine cervical remodeling during placentitis and the prepartum period: a transcriptomic approach.
Intrauterine Blood Plasma Platelet-Therapy Mitigates Persistent Breeding-Induced Endometritis, Reduces Uterine Infections, and Improves Embryo Recovery in Mares.
Steroid synthesis and metabolism in the equine placenta during placentitis.
Expression of estrogen receptor 1 and progesterone receptor in primary goat mammary epithelial cells.
Immunohistochemical localization of progesterone receptor isoforms and estrogen receptor alpha in the chicken oviduct magnum during development.
Mammary diffuse fibroadenomatoid hyperplasia in water buffalo (Bubalus bubalis): three cases.
Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
Histopathology as a simple and reliable method to detect 17β-oestradiol illegal treatment in male calves.
Epimorphin is a novel regulator of the progesterone receptor isoform-a.
A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.
Progestin treatment does not affect expression of cytokines, steroid receptors, oxytocin receptor, and cyclooxygenase 2 in fetal membranes and endometrium from pony mares at parturition.
Progesterone regulation of AVEN protects bovine oocytes from apoptosis during meiotic maturation.
Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.
Localization and hormonal regulation of endometrial matrix metalloproteinase-26 in the rhesus macaque.
Distribution of estrogen receptor α and progesterone receptor B in the bovine oviduct during the follicular and luteal phases of the sexual cycle: an immunohistochemical and semi-quantitative study.
Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
Localization of estrogen receptor α and progesterone receptor B in bovine cervix and vagina during the follicular and luteal phases of the sexual cycle.
The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.
In vitro characterization of ZK 230211--A type III progesterone receptor antagonist with enhanced antiproliferative properties.
Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis.
Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis.
Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats.
Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells.
Immunohistochemical localization of the estrogen receptor alpha (ERalpha) and progesterone receptor (PR) in the uterus of sika deer (Cervus nippon) during pregnancy.
Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Progesterone suppresses an oxytocin-stimulated signal pathway in COS-7 cells transfected with the oxytocin receptor.
Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
Immunohistochemical detection of receptors for oestrogen and progesterone in endometrial glands and stroma during the oestrous cycle in Nelore (Bos taurus indicus) cows.
Primary neuroendocrine carcinoma of the breast: a case report.
Primary neuroendocrine carcinoma of the breast: a case report.
MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
Expression profiles of sex steroid receptors in desmoid tumors.
Expression profiles of sex steroid receptors in desmoid tumors.
Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma.
Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism.
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters.
The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor.
Estradiol and medroxyprogesterone acetate regulated genes in T47D breast cancer cells.
p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Cytologic scoring of endometrioid adenocarcinoma of the endometrium.
Reduction of progesterone receptor expression in human cumulus cells at the time of oocyte collection during IVF is associated with good embryo quality.
Proteomic analysis of selected prognostic factors of breast cancer.
Human endometriotic xenografts in immunodeficient RAG-2/gamma(c)KO mice.
Steroid receptors in blood vessels of the rhesus macaque endometrium: a review.
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Changes in the presence of progesterone receptor isoforms in the oviduct magnum of newly-hatched chicks after gonadotropins treatment.
Changes in the presence of progesterone receptor isoforms in the oviduct magnum of newly-hatched chicks after gonadotropins treatment.
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Progesterone receptor isoforms in ovary of newly-hatched chick after gonadotropin treatment during embryonic development.
Progesterone receptor isoforms in ovary of newly-hatched chick after gonadotropin treatment during embryonic development.
Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors.
Unmasking the progesterone receptor in the preoptic area and hypothalamus of the ewe: no colocalization with gonadotropin-releasing neurons.
Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies.
Identification of progesterone receptor in human subcutaneous adipose tissue.
El-Sheikh Ali H, Scoggin KE, Ruby R, Loynachan A, Boakari Y, Fernandes C, Dini P, Fedorka CE, Loux SC, Esteller-Vico A, Ball BA
Reproduction (Cambridge, England) 2021 May 5;161(6):603-621
Reproduction (Cambridge, England) 2021 May 5;161(6):603-621
Intrauterine Blood Plasma Platelet-Therapy Mitigates Persistent Breeding-Induced Endometritis, Reduces Uterine Infections, and Improves Embryo Recovery in Mares.
Segabinazzi LGTM, Canisso IF, Podico G, Cunha LL, Novello G, Rosser MF, Loux SC, Lima FS, Alvarenga MA
Antibiotics (Basel, Switzerland) 2021 Apr 23;10(5)
Antibiotics (Basel, Switzerland) 2021 Apr 23;10(5)
Steroid synthesis and metabolism in the equine placenta during placentitis.
El-Sheikh Ali H, Legacki EL, Scoggin KE, Loux SC, Dini P, Esteller-Vico A, Conley AJ, Stanley SD, Ball BA
Reproduction (Cambridge, England) 2020 Mar;159(3):289-302
Reproduction (Cambridge, England) 2020 Mar;159(3):289-302
Expression of estrogen receptor 1 and progesterone receptor in primary goat mammary epithelial cells.
Ogorevc J, Dovč P
Animal science journal = Nihon chikusan Gakkaiho 2016 Dec;87(12):1464-1471
Animal science journal = Nihon chikusan Gakkaiho 2016 Dec;87(12):1464-1471
Immunohistochemical localization of progesterone receptor isoforms and estrogen receptor alpha in the chicken oviduct magnum during development.
González-Morán MG
Acta histochemica 2015 Oct;117(8):681-7
Acta histochemica 2015 Oct;117(8):681-7
Mammary diffuse fibroadenomatoid hyperplasia in water buffalo (Bubalus bubalis): three cases.
de Sant'Ana FJ, Carvalho FC, de O Gamba C, Cassali GD, Riet-Correa F, Schild AL
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2014 May;26(3):453-456
Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc 2014 May;26(3):453-456
Progesterone receptor-cyclin D1 complexes induce cell cycle-dependent transcriptional programs in breast cancer cells.
Dressing GE, Knutson TP, Schiewer MJ, Daniel AR, Hagan CR, Diep CH, Knudsen KE, Lange CA
Molecular endocrinology (Baltimore, Md.) 2014 Apr;28(4):442-57
Molecular endocrinology (Baltimore, Md.) 2014 Apr;28(4):442-57
Histopathology as a simple and reliable method to detect 17β-oestradiol illegal treatment in male calves.
Pezzolato M, Richelmi GB, Maurella C, Pitardi D, Varello K, Caramelli M, Bozzetta E
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 2013;30(6):1096-9
Food additives & contaminants. Part A, Chemistry, analysis, control, exposure & risk assessment 2013;30(6):1096-9
Epimorphin is a novel regulator of the progesterone receptor isoform-a.
Bascom JL, Radisky DC, Koh E, Fata JE, Lo A, Mori H, Roosta N, Hirai Y, Bissell MJ
Cancer research 2013 Sep 15;73(18):5719-29
Cancer research 2013 Sep 15;73(18):5719-29
A Common Docking Domain in Progesterone Receptor-B links DUSP6 and CK2 signaling to proliferative transcriptional programs in breast cancer cells.
Hagan CR, Knutson TP, Lange CA
Nucleic acids research 2013 Oct;41(19):8926-42
Nucleic acids research 2013 Oct;41(19):8926-42
Progestin treatment does not affect expression of cytokines, steroid receptors, oxytocin receptor, and cyclooxygenase 2 in fetal membranes and endometrium from pony mares at parturition.
Palm F, Walter I, Nowotny N, Budik S, Helmreich M, Aurich C
Theriogenology 2013 Jan 1;79(1):59-68
Theriogenology 2013 Jan 1;79(1):59-68
Progesterone regulation of AVEN protects bovine oocytes from apoptosis during meiotic maturation.
O'Shea LC, Hensey C, Fair T
Biology of reproduction 2013 Dec;89(6):146
Biology of reproduction 2013 Dec;89(6):146
Evidence for phenotypic plasticity in aggressive triple-negative breast cancer: human biology is recapitulated by a novel model system.
D'Amato NC, Ostrander JH, Bowie ML, Sistrunk C, Borowsky A, Cardiff RD, Bell K, Young LJ, Simin K, Bachelder RE, Delrow J, Dawson A, Yee LD, Mrózek K, Clay TM, Osada T, Seewaldt VL
PloS one 2012;7(9):e45684
PloS one 2012;7(9):e45684
Progesterone inhibits epithelial-to-mesenchymal transition in endometrial cancer.
van der Horst PH, Wang Y, Vandenput I, Kühne LC, Ewing PC, van Ijcken WF, van der Zee M, Amant F, Burger CW, Blok LJ
PloS one 2012;7(1):e30840
PloS one 2012;7(1):e30840
Validation of the aging hen (Gallus gallus domesticus) as an animal model for uterine leiomyomas.
Machado SA, Bahr JM, Hales DB, Braundmeier AG, Quade BJ, Nowak RA
Biology of reproduction 2012 Oct;87(4):86
Biology of reproduction 2012 Oct;87(4):86
Localization and hormonal regulation of endometrial matrix metalloproteinase-26 in the rhesus macaque.
Almeida-Francia CC, Keator CS, Mah K, Holden L, Hergert C, Slayden OD
Human reproduction (Oxford, England) 2012 Jun;27(6):1723-34
Human reproduction (Oxford, England) 2012 Jun;27(6):1723-34
Distribution of estrogen receptor α and progesterone receptor B in the bovine oviduct during the follicular and luteal phases of the sexual cycle: an immunohistochemical and semi-quantitative study.
Saruhan BG, Saǧsoz H, Akbalik ME, Ketani MA
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2011 Oct;86(5):315-25
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2011 Oct;86(5):315-25
Forkhead transcription factor FOXO1 is a direct target of progestin to inhibit endometrial epithelial cell growth.
Kyo S, Sakaguchi J, Kiyono T, Shimizu Y, Maida Y, Mizumoto Y, Mori N, Nakamura M, Takakura M, Miyake K, Sakamoto M, Inoue M
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Feb 1;17(3):525-37
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Feb 1;17(3):525-37
Localization of estrogen receptor α and progesterone receptor B in bovine cervix and vagina during the follicular and luteal phases of the sexual cycle.
Sağsöz H, Akbalik ME, Saruhan BG, Ketani MA
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2011 Aug;86(4):262-71
Biotechnic & histochemistry : official publication of the Biological Stain Commission 2011 Aug;86(4):262-71
The progesterone receptor hinge region regulates the kinetics of transcriptional responses through acetylation, phosphorylation, and nuclear retention.
Daniel AR, Gaviglio AL, Czaplicki LM, Hillard CJ, Housa D, Lange CA
Molecular endocrinology (Baltimore, Md.) 2010 Nov;24(11):2126-38
Molecular endocrinology (Baltimore, Md.) 2010 Nov;24(11):2126-38
In vitro characterization of ZK 230211--A type III progesterone receptor antagonist with enhanced antiproliferative properties.
Afhüppe W, Beekman JM, Otto C, Korr D, Hoffmann J, Fuhrmann U, Möller C
The Journal of steroid biochemistry and molecular biology 2010 Mar;119(1-2):45-55
The Journal of steroid biochemistry and molecular biology 2010 Mar;119(1-2):45-55
Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis.
Chakravarty D, Gupta N, Goda JS, Srinivasan R, Patel FD, Dhaliwal L
Acta histochemica 2010 Jul;112(4):355-63
Acta histochemica 2010 Jul;112(4):355-63
Columnar cell lesions of the canine mammary gland: pathological features and immunophenotypic analysis.
Ferreira E, Gobbi H, Saraiva BS, Cassali GD
BMC cancer 2010 Feb 23;10:61
BMC cancer 2010 Feb 23;10:61
Expression of membrane progesterone receptors (mPR/PAQR) in ovarian cancer cells: implications for progesterone-induced signaling events.
Charles NJ, Thomas P, Lange CA
Hormones & cancer 2010 Aug;1(4):167-76
Hormones & cancer 2010 Aug;1(4):167-76
Assessment of the tumorigenesis and drug susceptibility of three new canine mammary tumor cell lines.
Chang CY, Chiou PP, Chen WJ, Li YH, Yiu JC, Cheng YH, Chen SD, Lin CT, Lai YS
Research in veterinary science 2010 Apr;88(2):285-93
Research in veterinary science 2010 Apr;88(2):285-93
Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.
Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, Veldscholte J, van Doorn HC, Ewing PC, Kim JJ, Grootegoed JA, Burger CW, Fodde R, Blok LJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Sep 15;15(18):5784-93
Clinical cancer research : an official journal of the American Association for Cancer Research 2009 Sep 15;15(18):5784-93
HER-2/neu (c-erbB-2) oncoprotein in hyperplastic endometrial polyps detected in two cats.
Misirlioglu D, Nak D, Ozyigit MO, Nak Y, Akkoc A
Journal of feline medicine and surgery 2009 Oct;11(10):885-8
Journal of feline medicine and surgery 2009 Oct;11(10):885-8
Dexamethasone down-regulates ABCG2 expression levels in breast cancer cells.
Honorat M, Mesnier A, Di Pietro A, Lin V, Cohen P, Dumontet C, Payen L
Biochemical and biophysical research communications 2008 Oct 24;375(3):308-14
Biochemical and biophysical research communications 2008 Oct 24;375(3):308-14
Immunohistochemical localization of the estrogen receptor alpha (ERalpha) and progesterone receptor (PR) in the uterus of sika deer (Cervus nippon) during pregnancy.
Yanagawa Y, Matsuura Y, Suzuki M, Katagiri S, Tsubota T
The Japanese journal of veterinary research 2008 Nov;56(3):139-49
The Japanese journal of veterinary research 2008 Nov;56(3):139-49
Regulation of ovarian cancer cell viability and sensitivity to cisplatin by progesterone receptor membrane component-1.
Peluso JJ, Liu X, Saunders MM, Claffey KP, Phoenix K
The Journal of clinical endocrinology and metabolism 2008 May;93(5):1592-9
The Journal of clinical endocrinology and metabolism 2008 May;93(5):1592-9
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
Bao H, Yu D, Wang J, Qiu T, Yang J, Wang L
Anti-cancer drugs 2008 Mar;19(3):317-23
Anti-cancer drugs 2008 Mar;19(3):317-23
Predictive value of serum anti-p53 antibodies, carcino-embryonic antigen, carbohydrate antigen 15-3, estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in taxane-based and anthracycline-based neoadjuvant chemotherapy in locally advanced breast cancer patients.
Bao H, Yu D, Wang J, Qiu T, Yang J, Wang L
Anti-cancer drugs 2008 Mar;19(3):317-23
Anti-cancer drugs 2008 Mar;19(3):317-23
Anti-estrogenic mechanism of unliganded progesterone receptor isoform B in breast cancer cells.
Zheng ZY, Zheng SM, Bay BH, Aw SE, C-L Lin V
Breast cancer research and treatment 2008 Jul;110(1):111-25
Breast cancer research and treatment 2008 Jul;110(1):111-25
Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.
Chakravarty D, Srinivasan R, Ghosh S, Rajwanshi A, Gopalan S
Applied immunohistochemistry & molecular morphology : AIMM 2008 Dec;16(6):535-42
Applied immunohistochemistry & molecular morphology : AIMM 2008 Dec;16(6):535-42
Progesterone suppresses an oxytocin-stimulated signal pathway in COS-7 cells transfected with the oxytocin receptor.
Bishop CV, Filtz T, Zhang Y, Slayden O, Stormshak F
Steroids 2008 Dec 22;73(14):1367-74
Steroids 2008 Dec 22;73(14):1367-74
Carcinoma-associated fibroblasts activate progesterone receptors and induce hormone independent mammary tumor growth: A role for the FGF-2/FGFR-2 axis.
Giulianelli S, Cerliani JP, Lamb CA, Fabris VT, Bottino MC, Gorostiaga MA, Novaro V, Góngora A, Baldi A, Molinolo A, Lanari C
International journal of cancer 2008 Dec 1;123(11):2518-31
International journal of cancer 2008 Dec 1;123(11):2518-31
Immunohistochemical detection of receptors for oestrogen and progesterone in endometrial glands and stroma during the oestrous cycle in Nelore (Bos taurus indicus) cows.
Martin I, Torres Neto R, Oba E, Buratini J Jr, Binelli M, Laufer-Amorim R, Ferreira JC
Reproduction in domestic animals = Zuchthygiene 2008 Aug;43(4):415-21
Reproduction in domestic animals = Zuchthygiene 2008 Aug;43(4):415-21
Primary neuroendocrine carcinoma of the breast: a case report.
Yaren A, Kelten C, Akbulut M, Teke Z, Duzcan E, Erdem E
Tumori 2007 Sep-Oct;93(5):496-8
Tumori 2007 Sep-Oct;93(5):496-8
Primary neuroendocrine carcinoma of the breast: a case report.
Yaren A, Kelten C, Akbulut M, Teke Z, Duzcan E, Erdem E
Tumori 2007 Sep-Oct;93(5):496-8
Tumori 2007 Sep-Oct;93(5):496-8
MUC1 expression is repressed by protein inhibitor of activated signal transducer and activator of transcription-y.
Brayman MJ, Dharmaraj N, Lagow E, Carson DD
Molecular endocrinology (Baltimore, Md.) 2007 Nov;21(11):2725-37
Molecular endocrinology (Baltimore, Md.) 2007 Nov;21(11):2725-37
Progesterone receptors upregulate Wnt-1 to induce epidermal growth factor receptor transactivation and c-Src-dependent sustained activation of Erk1/2 mitogen-activated protein kinase in breast cancer cells.
Faivre EJ, Lange CA
Molecular and cellular biology 2007 Jan;27(2):466-80
Molecular and cellular biology 2007 Jan;27(2):466-80
Linkage of progestin and epidermal growth factor signaling: phosphorylation of progesterone receptors mediates transcriptional hypersensitivity and increased ligand-independent breast cancer cell growth.
Daniel AR, Qiu M, Faivre EJ, Ostrander JH, Skildum A, Lange CA
Steroids 2007 Feb;72(2):188-201
Steroids 2007 Feb;72(2):188-201
Expression profiles of sex steroid receptors in desmoid tumors.
Ishizuka M, Hatori M, Dohi O, Suzuki T, Miki Y, Tazawa C, Sasano H, Kokubun S
The Tohoku journal of experimental medicine 2006 Nov;210(3):189-98
The Tohoku journal of experimental medicine 2006 Nov;210(3):189-98
Expression profiles of sex steroid receptors in desmoid tumors.
Ishizuka M, Hatori M, Dohi O, Suzuki T, Miki Y, Tazawa C, Sasano H, Kokubun S
The Tohoku journal of experimental medicine 2006 Nov;210(3):189-98
The Tohoku journal of experimental medicine 2006 Nov;210(3):189-98
Progesterone receptor isoforms as a prognostic marker in human endometrial carcinoma.
Saito S, Ito K, Nagase S, Suzuki T, Akahira J, Okamura K, Yaegashi N, Sasano H
Cancer science 2006 Dec;97(12):1308-14
Cancer science 2006 Dec;97(12):1308-14
Progesterone regulation of human granulosa/luteal cell viability by an RU486-independent mechanism.
Engmann L, Losel R, Wehling M, Peluso JJ
The Journal of clinical endocrinology and metabolism 2006 Dec;91(12):4962-8
The Journal of clinical endocrinology and metabolism 2006 Dec;91(12):4962-8
The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.
Hanifi-Moghaddam P, Sijmons B, Ott MC, van Ijcken WF, Nowzari D, Kuhne EC, van der Spek P, Kloosterboer HJ, Burger CW, Blok LJ
Journal of molecular endocrinology 2006 Dec;37(3):405-13
Journal of molecular endocrinology 2006 Dec;37(3):405-13
Chemokine receptor CXCR4 expression in breast cancer as a potential predictive marker of isolated tumor cells in bone marrow.
Cabioglu N, Sahin A, Doucet M, Yavuz E, Igci A, O Yildirim E, Aktas E, Bilgic S, Kiran B, Deniz G, Price JE
Clinical & experimental metastasis 2005;22(1):39-46
Clinical & experimental metastasis 2005;22(1):39-46
The presence of serum anti-p53 antibodies from patients with invasive ductal carcinoma of breast: correlation to other clinical and biological parameters.
Gao RJ, Bao HZ, Yang Q, Cong Q, Song JN, Wang L
Breast cancer research and treatment 2005 Sep;93(2):111-5
Breast cancer research and treatment 2005 Sep;93(2):111-5
The expression of Ki-67, p53, estrogen and progesterone receptors affecting survival in uterine leiomyosarcomas. A clinicopathologic study.
Akhan SE, Yavuz E, Tecer A, Iyibozkurt CA, Topuz S, Tuzlali S, Bengisu E, Berkman S
Gynecologic oncology 2005 Oct;99(1):36-42
Gynecologic oncology 2005 Oct;99(1):36-42
Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor.
Leo JC, Wang SM, Guo CH, Aw SE, Zhao Y, Li JM, Hui KM, Lin VC
International journal of cancer 2005 Nov 20;117(4):561-8
International journal of cancer 2005 Nov 20;117(4):561-8
Estradiol and medroxyprogesterone acetate regulated genes in T47D breast cancer cells.
Mrusek S, Classen-Linke I, Vloet A, Beier HM, Krusche CA
Molecular and cellular endocrinology 2005 May 12;235(1-2):39-50
Molecular and cellular endocrinology 2005 May 12;235(1-2):39-50
p21WAF1/CIP1 selectively controls the transcriptional activity of estrogen receptor alpha.
Fritah A, Saucier C, Mester J, Redeuilh G, Sabbah M
Molecular and cellular biology 2005 Mar;25(6):2419-30
Molecular and cellular biology 2005 Mar;25(6):2419-30
Progesterone receptor isoform identification and subcellular localization in endometrial cancer.
Leslie KK, Stein MP, Kumar NS, Dai D, Stephens J, Wandinger-Ness A, Glueck DH
Gynecologic oncology 2005 Jan;96(1):32-41
Gynecologic oncology 2005 Jan;96(1):32-41
Progesterone receptors induce cell cycle progression via activation of mitogen-activated protein kinases.
Skildum A, Faivre E, Lange CA
Molecular endocrinology (Baltimore, Md.) 2005 Feb;19(2):327-39
Molecular endocrinology (Baltimore, Md.) 2005 Feb;19(2):327-39
Cytologic scoring of endometrioid adenocarcinoma of the endometrium.
Nishimura Y, Watanabe J, Jobo T, Hattori M, Arai T, Kuramoto H
Cancer 2005 Feb 25;105(1):8-12
Cancer 2005 Feb 25;105(1):8-12
Reduction of progesterone receptor expression in human cumulus cells at the time of oocyte collection during IVF is associated with good embryo quality.
Hasegawa J, Yanaihara A, Iwasaki S, Otsuka Y, Negishi M, Akahane T, Okai T
Human reproduction (Oxford, England) 2005 Aug;20(8):2194-200
Human reproduction (Oxford, England) 2005 Aug;20(8):2194-200
Proteomic analysis of selected prognostic factors of breast cancer.
Roberts K, Bhatia K, Stanton P, Lord R
Proteomics 2004 Mar;4(3):784-92
Proteomics 2004 Mar;4(3):784-92
Human endometriotic xenografts in immunodeficient RAG-2/gamma(c)KO mice.
Greenberg LH, Slayden OD
American journal of obstetrics and gynecology 2004 Jun;190(6):1788-95; discussion 1795-6
American journal of obstetrics and gynecology 2004 Jun;190(6):1788-95; discussion 1795-6
Steroid receptors in blood vessels of the rhesus macaque endometrium: a review.
Brenner RM, Slayden OD
Archives of histology and cytology 2004 Dec;67(5):411-6
Archives of histology and cytology 2004 Dec;67(5):411-6
The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
Guler G, Uner A, Guler N, Han SY, Iliopoulos D, Hauck WW, McCue P, Huebner K
Cancer 2004 Apr 15;100(8):1605-14
Cancer 2004 Apr 15;100(8):1605-14
Consequences of loss of progesterone receptor expression in development of invasive endometrial cancer.
Hanekamp EE, Gielen SC, Smid-Koopman E, Kühne LC, de Ruiter PE, Chadha-Ajwani S, Brinkmann AO, Grootegoed JA, Burger CW, Huikeshoven FJ, Blok LJ
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Sep 15;9(11):4190-9
Clinical cancer research : an official journal of the American Association for Cancer Research 2003 Sep 15;9(11):4190-9
Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Abd-Elaziz M, Akahira J, Moriya T, Suzuki T, Yaegashi N, Sasano H
Cancer science 2003 Nov;94(11):980-5
Cancer science 2003 Nov;94(11):980-5
Nuclear receptor DAX-1 in human common epithelial ovarian carcinoma: an independent prognostic factor of clinical outcome.
Abd-Elaziz M, Akahira J, Moriya T, Suzuki T, Yaegashi N, Sasano H
Cancer science 2003 Nov;94(11):980-5
Cancer science 2003 Nov;94(11):980-5
Changes in the presence of progesterone receptor isoforms in the oviduct magnum of newly-hatched chicks after gonadotropins treatment.
González-Morán G, Camacho-Arroyo I
Life sciences 2003 Jul 4;73(7):871-82
Life sciences 2003 Jul 4;73(7):871-82
Changes in the presence of progesterone receptor isoforms in the oviduct magnum of newly-hatched chicks after gonadotropins treatment.
González-Morán G, Camacho-Arroyo I
Life sciences 2003 Jul 4;73(7):871-82
Life sciences 2003 Jul 4;73(7):871-82
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Joki-Erkkilä MM, Karikoski R, Rantala I, Lenko HL, Visakorpi T, Heinonen PK
Journal of pediatric and adolescent gynecology 2002 Jun;15(3):145-9
Journal of pediatric and adolescent gynecology 2002 Jun;15(3):145-9
Gonadoblastoma and dysgerminoma associated with XY gonadal dysgenesis in an adolescent with chronic renal failure: a case of Frasier syndrome.
Joki-Erkkilä MM, Karikoski R, Rantala I, Lenko HL, Visakorpi T, Heinonen PK
Journal of pediatric and adolescent gynecology 2002 Jun;15(3):145-9
Journal of pediatric and adolescent gynecology 2002 Jun;15(3):145-9
Progesterone receptor isoforms in ovary of newly-hatched chick after gonadotropin treatment during embryonic development.
González-Morán G, García-Izquierdo J, Camacho-Arroyo I
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 2002 Jun;132(2):519-26
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 2002 Jun;132(2):519-26
Progesterone receptor isoforms in ovary of newly-hatched chick after gonadotropin treatment during embryonic development.
González-Morán G, García-Izquierdo J, Camacho-Arroyo I
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 2002 Jun;132(2):519-26
Comparative biochemistry and physiology. Part A, Molecular & integrative physiology 2002 Jun;132(2):519-26
Differential expression of progesterone receptor isoforms A and B in the normal ovary, and in benign, borderline, and malignant ovarian tumors.
Akahira J, Suzuki T, Ito K, Kaneko C, Darnel AD, Moriya T, Okamura K, Yaegashi N, Sasano H
Japanese journal of cancer research : Gann 2002 Jul;93(7):807-15
Japanese journal of cancer research : Gann 2002 Jul;93(7):807-15
Unmasking the progesterone receptor in the preoptic area and hypothalamus of the ewe: no colocalization with gonadotropin-releasing neurons.
Skinner DC, Caraty A, Allingham R
Endocrinology 2001 Feb;142(2):573-9
Endocrinology 2001 Feb;142(2):573-9
Progesterone receptor isoforms A and B in human epithelial ovarian carcinoma: immunohistochemical and RT-PCR studies.
Akahira J, Inoue T, Suzuki T, Ito K, Konno R, Sato S, Moriya T, Okamura K, Yajima A, Sasano H
British journal of cancer 2000 Dec;83(11):1488-94
British journal of cancer 2000 Dec;83(11):1488-94
Identification of progesterone receptor in human subcutaneous adipose tissue.
O'Brien SN, Welter BH, Mantzke KA, Price TM
The Journal of clinical endocrinology and metabolism 1998 Feb;83(2):509-13
The Journal of clinical endocrinology and metabolism 1998 Feb;83(2):509-13
No comments: Submit comment
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Western blot analysis of Progesterone Receptor was performed by loading 20 µg of T47D cell lysates, untreated (-) or stimulated (+) with 100 nm promegestone (R5020) for 1 hour and 10 µL PageRuler Plus Prestained Protein Ladder (Product # 26619) per well onto a 4-20% Tris-Glycine polyacrylamide gel. Proteins were transferred to a nitrocellulose membrane using the G2 Fast Blotter (Product # 62288) and blocked with 5% Milk/TBST for at least 1 hour at room temperature. Progesterone Receptor was detected using a Progesterone Receptor mouse monoclonal antibody, Product # MA1-12626, at a concentration of 1 µg/mL in blocking buffer overnight at 4°C on a rocking platform, followed by a Superclonal goat anti-Mouse IgG-HRP secondary antibody (Product # A28177) at a dilution of 1:2,000 for at least 1 hour at room temperature. Chemiluminescent detection was performed using SuperSignal West Pico (Product # 34078) and the myECL Imager (Product # 62236).
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescent analysis of Progesterone Receptor (green) in T47D cells untreated (left) or stimulated with 100nm promegestone, R5020, for 1 hour (right). The cells were fixed with formalin for 15 minutes, permeabilized with 0.1% Triton X-100 in TBS for 10 minutes, and blocked with 3% Blocker BSA (Product # 37525) for 15 minutes at room temperature. Cells were stained with Progesterone Receptor mouse monoclonal antibody (Product # MA1-12626), at a dilution of 1:100 for 1 hour at 37C, and then incubated with a Alexa Fluor 488 Superclonal goat anti-mouse IgG secondary antibody (Product # A28175) at a dilution of 1:1000 for 30 minutes at room temperature (both panels, green). Nuclei (both panels, blue) were stained with Hoechst 33342 dye (Product # 62249). Images were taken on a Thermo Scientific ToxInsight at 20X magnification.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Immunofluorescence analysis of Progesterone Receptor was performed using 70% confluent log phase T-47D cells. The cells were fixed with 4% paraformaldehyde for 10 minutes, permeabilized with 0.1% Triton™ X-100 for 15 minutes, and blocked with 1% BSA for 1 hour at room temperature. The cells were labeled with Progesterone Receptor Monoclonal Antibody (hPRa2 + hPRa3) (Product # MA1-12626) at 1:100 dilution in 0.1% BSA, incubated at 4 degree Celsius overnight and then labeled with Goat anti-Mouse IgG (H+L) Superclonal™ Secondary Antibody, Alexa Fluor® 488 conjugate (Product # A28175) at a dilution of 1:2000 for 45 minutes at room temperature (Panel a: green). Nuclei (Panel b: blue) were stained with SlowFade® Gold Antifade Mountant with DAPI (Product # S36938). F-actin (Panel c: red) was stained with Rhodamine Phalloidin (Product # R415, 1:300). Panel d represents the merged image showing nuclear localization. Panel e represents control cells with no primary antibody to assess background. Panel f shows the absence of Progesterone Receptor expression in the negative model, SK-BR-3.The images were captured at 60X magnification.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Enrichment of endogenous Progesterone Receptor protein at specific gene loci using Anti-Progesterone Receptor Antibody: Chromatin Immunoprecipitation (ChIP) was performed using Anti-Progesterone Receptor Mouse Antibody (Product # MA1-12626, 4 ul) on sheared chromatin from 2 million T-47D cells using the MAGnify ChIP System (Product # 49-2024). Normal Rabbit IgG was used as a negative IP control. The purified DNA was analyzed by qPCR with PCR primer pairs over the progesterone receptor elements (PRE) in the DUSP1 gene, DUSP1 PRE1 (+197 kb) (active) and the DUSP1 PRE4 (-463 kb) (inactive). Data is presented as fold enrichment of the antibody signal versus the negative control IgG using the comparative CT method.
Supportive validation
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Double immunofluorescence stainings of the primary goat mammary epithelial cells (pgMECs), grown in lactogenic conditions. (A) Co-distribution of estrogen receptor alpha (ER-alpha)/cytokeratin 18 (CK18) shows that many, but not all, ER-alpha (green) positive cells are also positive for luminal lineage marker CK18 (red). (B) Co-staining of ER-alpha/progesterone receptor (PGR) shows that cells expressing the steroid receptors can be either ER-alpha (green), PGR (red) or ER-alpha/PGR (orange) positive. Scale bars = 50 um.
- Submitted by
- Invitrogen Antibodies (provider)
- Main image
- Experimental details
- Double immunofluorescence stainings of the primary goat mammary epithelial cells (pgMECs), grown in lactogenic conditions. (A) Co-distribution of estrogen receptor alpha (ER-alpha)/cytokeratin 18 (CK18) shows that many, but not all, ER-alpha (green) positive cells are also positive for luminal lineage marker CK18 (red). (B) Co-staining of ER-alpha/progesterone receptor (PGR) shows that cells expressing the steroid receptors can be either ER-alpha (green), PGR (red) or ER-alpha/PGR (orange) positive. Scale bars = 50 um.